Korea Otsuka Pharmaceutical Co., Ltd.
Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder
- Conditions
- Chronic Motor or Vocal Tic DisorderTourette's Disorder
- Interventions
- Drug: placebo
- First Posted Date
- 2008-06-27
- Last Posted Date
- 2013-07-26
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 61
- Registration Number
- NCT00706589
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷Inha University Hospital, Inchon, Korea, Republic of
🇰🇷Yonsei University Severance Hospital, Seoul, Korea, Republic of
An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors
- Conditions
- Solid Tumor
- First Posted Date
- 2008-04-14
- Last Posted Date
- 2008-04-18
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT00657176
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity
- Conditions
- Rheumatoid ArthritisOsteoarthritisAnkylosing Spondylitis
- Interventions
- First Posted Date
- 2007-12-19
- Last Posted Date
- 2011-11-16
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 396
- Registration Number
- NCT00576706
Safety and Pharmacokinetics of Probucol and Cilostazol
- First Posted Date
- 2007-10-26
- Last Posted Date
- 2022-03-04
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT00549978
- Locations
- 🇰🇷
Clinical Trial Center, Seoul National University Hospital, Seoul, Korea, Republic of
Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer Patients
- Conditions
- Oral Mucositis
- First Posted Date
- 2007-10-26
- Last Posted Date
- 2007-10-26
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Registration Number
- NCT00549952
- Locations
- 🇰🇷
Seoul National University hospital, Seoul, Korea, Republic of
Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness
- Conditions
- Bipolar Disorder
- Interventions
- Drug: Abilify(aripiprazole)
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2010-08-12
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 146
- Registration Number
- NCT00545675
- Locations
- 🇰🇷
St. Mary's Hospital, Seoul, Korea, Republic of
Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
- Conditions
- Bipolar Disorder
- First Posted Date
- 2007-10-17
- Last Posted Date
- 2010-06-25
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 280
- Registration Number
- NCT00545142
- Locations
- 🇰🇷
St. Mary's hospital, Seoul, Korea, Republic of
Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)
- Conditions
- SchizophreniaSchizoaffective Disorder
- First Posted Date
- 2006-03-20
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 300
- Registration Number
- NCT00304655
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
SWitching to Abilify Trial (SWAT)
- Conditions
- Schizophrenia
- First Posted Date
- 2006-03-20
- Last Posted Date
- 2009-12-17
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 500
- Registration Number
- NCT00304616
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
Cilostazol in Acute Ischemic Stroke Treatment (CAIST)
- Conditions
- Cerebral Infarction
- First Posted Date
- 2006-01-06
- Last Posted Date
- 2009-12-16
- Lead Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 468
- Registration Number
- NCT00272454
- Locations
- 🇰🇷
Hallym University Sacred Heart Hospital, Ahnyang, Kyunggi Province, Korea, Republic of
🇰🇷Inje University Ilsan Paik Hospital, Koyang, Kyunggi Province, Korea, Republic of
🇰🇷Seoul National University Bundang Hospital, Sungnam, Kyunggi Province, Korea, Republic of